Singular Genomics Systems
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Singular Genomics Systems generated cash of -$73,647,000, which is more than the previous year. Cash used in financing activities reached the amount of $696,000 last year. Net change in cash is therefore -$59,144,000.
Cash Flow
| 2019 | -11.39M | -31.5M | 47.30M |
|---|---|---|---|
| 2020 | -24.87M | 24.00M | 7.51M |
| 2021 | -51.70M | -130.86M | 372.12M |
| 2022 | -87.09M | -39.56M | 901K |
| 2023 | -73.64M | 13.80M | 696K |
OMIC Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 75.97M | 201.73M | 12.17M | 5.52M | 1.11M |
Operating activities | |||||
Net income | -94.82M | -90.87M | -98.77M | -27.94M | -12.32M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 7.22M | 6.03M | 1.13M | 639K | 350K |
Stock-based compensation expense | 11.40M | 13.66M | 9.23M | 1.06M | 170K |
| Deferred income tax benefit | 11.40M | 13.66M | 9.23M | 1.06M | 170K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 348K | -913K | 0 | 0 | 0 |
Inventories | -3.53M | -13.48M | 0 | 0 | 0 |
Accounts payable | 267K | -1.16M | 1.85M | -148K | 244K |
Cash generated by operating activities | -73.64M | -87.09M | -51.70M | -24.87M | -11.39M |
Investing activities | |||||
Purchases Of Investments | -183.59M | -174.71M | -195.68M | -6.07M | -42.72M |
Investments In Property Plant And Equipment | -970K | -6.02M | -4.86M | -1.38M | -800K |
Acquisitions Net | 0 | 33.54M | 125.99M | -25.38M | 30.7M |
Cash generated by investing activities | 13.80M | -39.56M | -130.86M | 24.00M | -31.5M |
Financing activities | |||||
Common Stock Issued | 0 | 0 | 240.77M | 17K | 41K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -19K | -450K | 3.57M | -2K | 0 |
Repayments of term debt | 0 | 0 | -10.4M | -7.5M | 2.46M |
Cash used in financing activities | 696K | 901K | 372.12M | 7.51M | 47.30M |
Net Change In Cash | -59.14M | -125.75M | 189.56M | 6.64M | 4.40M |
Cash at end of period | 16.83M | 75.97M | 201.73M | 12.17M | 5.52M |
| Data source | Data source | Data source |